Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BYRN - US12448X2018 - Common Stock

17.45 USD
+0.47 (+2.77%)
Last: 11/21/2025, 8:15:12 PM
16.76 USD
-0.69 (-3.95%)
After Hours: 11/21/2025, 8:15:12 PM
Fundamental Rating

6

Overall BYRN gets a fundamental rating of 6 out of 10. We evaluated BYRN against 71 industry peers in the Aerospace & Defense industry. BYRN has an excellent financial health rating, but there are some minor concerns on its profitability. BYRN is valued quite expensively, but it does show have an excellent growth rating. These ratings would make BYRN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
BYRN had a negative operating cash flow in the past year.
BYRN had negative earnings in 4 of the past 5 years.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

The Return On Assets of BYRN (20.36%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 25.33%, BYRN belongs to the best of the industry, outperforming 94.37% of the companies in the same industry.
With an excellent Return On Invested Capital value of 14.57%, BYRN belongs to the best of the industry, outperforming 92.96% of the companies in the same industry.
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROIC 14.57%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

With an excellent Profit Margin value of 14.43%, BYRN belongs to the best of the industry, outperforming 91.55% of the companies in the same industry.
BYRN has a better Operating Margin (10.81%) than 71.83% of its industry peers.
BYRN's Gross Margin of 61.32% is amongst the best of the industry. BYRN outperforms 94.37% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BYRN is creating some value.
Compared to 1 year ago, BYRN has more shares outstanding
The number of shares outstanding for BYRN has been increased compared to 5 years ago.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 17.12. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
BYRN has a better Altman-Z score (17.12) than 97.18% of its industry peers.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.12
ROIC/WACC1.52
WACC9.61%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BYRN has a Current Ratio of 4.21. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
BYRN's Current ratio of 4.21 is amongst the best of the industry. BYRN outperforms 83.10% of its industry peers.
BYRN has a Quick Ratio of 1.71. This is a normal value and indicates that BYRN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.71, BYRN is in the better half of the industry, outperforming 66.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 1.71
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

BYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 235.00%, which is quite impressive.
Looking at the last year, BYRN shows a very strong growth in Revenue. The Revenue has grown by 50.99%.
Measured over the past years, BYRN shows a very strong growth in Revenue. The Revenue has been growing by 147.68% on average per year.
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%

3.2 Future

The Earnings Per Share is expected to grow by 11.53% on average over the next years. This is quite good.
The Revenue is expected to grow by 18.79% on average over the next years. This is quite good.
EPS Next Y-30.49%
EPS Next 2Y6.16%
EPS Next 3Y11.53%
EPS Next 5YN/A
Revenue Next Year37.26%
Revenue Next 2Y28.59%
Revenue Next 3Y20.01%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.04, BYRN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BYRN is valued a bit cheaper than 78.87% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.45, BYRN is valued at the same level.
Based on the Price/Forward Earnings ratio of 24.97, the valuation of BYRN can be described as rather expensive.
Based on the Price/Forward Earnings ratio, BYRN is valued a bit cheaper than 73.24% of the companies in the same industry.
BYRN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.46.
Industry RankSector Rank
PE 26.04
Fwd PE 24.97
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.56
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

BYRN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.16%
EPS Next 3Y11.53%

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (11/21/2025, 8:15:12 PM)

After market: 16.76 -0.69 (-3.95%)

17.45

+0.47 (+2.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-09 2025-10-09/bmo
Earnings (Next)12-08 2025-12-08/bmo
Inst Owners65.32%
Inst Owner Change-0.42%
Ins Owners19.32%
Ins Owner Change-11.21%
Market Cap396.64M
Revenue(TTM)110.85M
Net Income(TTM)16.00M
Analysts83.64
Price Target40.49 (132.03%)
Short Float %21.37%
Short Ratio7.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.45%
Min EPS beat(2)21.04%
Max EPS beat(2)37.87%
EPS beat(4)4
Avg EPS beat(4)102.42%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)7
Avg EPS beat(8)85.45%
EPS beat(12)9
Avg EPS beat(12)5.69%
EPS beat(16)10
Avg EPS beat(16)-7.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)7.51%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)3.12%
PT rev (3m)3.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.96%
EPS NY rev (1m)0%
EPS NY rev (3m)7.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 26.04
Fwd PE 24.97
P/S 3.58
P/FCF N/A
P/OCF N/A
P/B 6.28
P/tB 6.87
EV/EBITDA 27.56
EPS(TTM)0.67
EY3.84%
EPS(NY)0.7
Fwd EY4%
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS4.88
BVpS2.78
TBVpS2.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.47
Profitability
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROCE 18.44%
ROIC 14.57%
ROICexc 16.91%
ROICexgc 18.72%
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 340.6%
Cap/Sales 6.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 1.71
Altman-Z 17.12
F-Score7
WACC9.61%
ROIC/WACC1.52
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y-30.49%
EPS Next 2Y6.16%
EPS Next 3Y11.53%
EPS Next 5YN/A
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%
Revenue Next Year37.26%
Revenue Next 2Y28.59%
Revenue Next 3Y20.01%
Revenue Next 5Y18.79%
EBIT growth 1Y601.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.26%
EBIT Next 3Y92.43%
EBIT Next 5Y53.44%
FCF growth 1Y-82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.34%
OCF growth 3YN/A
OCF growth 5YN/A

BYRNA TECHNOLOGIES INC / BYRN FAQ

What is the ChartMill fundamental rating of BYRNA TECHNOLOGIES INC (BYRN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BYRN.


Can you provide the valuation status for BYRNA TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 3 / 10 to BYRNA TECHNOLOGIES INC (BYRN). This can be considered as Overvalued.


How profitable is BYRNA TECHNOLOGIES INC (BYRN) stock?

BYRNA TECHNOLOGIES INC (BYRN) has a profitability rating of 6 / 10.


What is the earnings growth outlook for BYRNA TECHNOLOGIES INC?

The Earnings per Share (EPS) of BYRNA TECHNOLOGIES INC (BYRN) is expected to decline by -30.49% in the next year.